Precision Medicine - Obama’s Health Care Legacy

19 December 2016 Personalized Medicine Bulletin Blog
Authors: Antoinette F. Konski

As we come to the end of President Obama’s administration, it is time to look back on the past eight years and the administration’s impact on the delivery of the nation’s health care. While the Affordable Care Act (signed into law early in the President’s administration on March 23rd, 2010) is a significant achievement in that it provided many Americans access to health care, one cannot dismiss the President’s transformative commitment to precision or personalized medicine.

In 2006 as a then junior senator, President Obama introduced the Genomics and Personalized Medicine Act to improve access to and utilization of valid, reliable genetic tests and to secure the promise of personalized medicine for all Americans. While neither President Obama’s bill nor subsequent versions were enacted into law, many of the elements of the bills were incorporated into, and expanded upon, in the recently enacted 21st Century Cures Act (the “Act”).  Signed into law by the President on December 13th, 2016, the Act passed the House of Representatives (392-26) and Senate (94-5) with overwhelming bipartisan support.

The Act secures $4.8 billion in funding for the necessary infrastructure to advance precision medicine. This includes funding to the National Institutes of Health to support the President’s Precision Medicine Initiative ($1.5 billion) and to Vice President Biden’s “Cancer Moonshot” initiative ($1.8 billion). Spending under the Act will advance precision medicine more specifically by developing:

  • New approaches for addressing scientific, medical, public health and regulatory issues;
  • New genomic-based technologies;
  • New private-public partnerships to better leverage data sources and interpretation;
  • New expanded sources of genetic and clinical information; and
  • Improved regulations and laws to protect human participants and their private health care information.

We can all look back with gratitude to President Obama’s leadership in the advancement of personalized medicine and the modernization of the tools necessary to advance its promise.

A copy of the Bill and a concise summary provided by The Energy and Commerce Committee can be found here.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services